(Q41748948)

8 October 2017

title

Clinical outcomes in women with breast cancer and a PALB2 mutation: a prospective cohort analysis (English)

1 reference

8 October 2017

1

Cezary Cybulski

1 reference

8 October 2017

16

Jan Lubiński

1 reference

8 October 2017

6

Anna Jakubowska

1 reference

8 October 2017

8

Tomasz Byrski

1 reference

8 October 2017

15

Steven A Narod

1 reference

8 October 2017

3

Tomasz Huzarski

1 reference

8 October 2017

9

Tadeusz Dębniak

1 reference

8 October 2017

14

Jacek Gronwald

1 reference

8 October 2017

10

Bohdan Górski

1 reference

8 October 2017

5

Aniruddh Kashyap

1 reference

8 October 2017

12

Mohammad R Akbari

1 reference

8 October 2017

4

Dominika Wokołorczyk

1 reference

8 October 2017

2

Wojciech Kluźniak

1 reference

8 October 2017

7

Marek Szwiec

1 reference

Polish Hereditary Breast Cancer Consortium

8 October 2017

series ordinal

17

object named as

Polish Hereditary Breast Cancer Consortium

1 reference

8 October 2017

Victoria Sopik

11

1 reference

8 October 2017

Ping Sun

series ordinal

13

1 reference

8 October 2017

language of work or name

1 reference

7 May 2015

1 reference

Lancet Oncology Commission

8 October 2017

published in

1 reference

8 October 2017

volume

16

1 reference

8 October 2017

issue

6

1 reference

8 October 2017

page(s)

638-644

1 reference

Penetrance analysis of the PALB2 c.1592delT founder mutation

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

A PALB2 germline mutation associated with hereditary breast cancer in Italy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

A PALB2 mutation associated with high risk of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

The PALB2 gene is a strong candidate for clinical testing in BRCA1- and BRCA2-negative hereditary breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Breast-cancer risk in families with mutations in PALB2

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

A recurrent mutation in PALB2 in Finnish cancer families.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

A novel germline PALB2 deletion in Polish breast and ovarian cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Utilization of multigene panels in hereditary cancer predisposition testing: analysis of more than 2,000 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Frequency of mutations in individuals with breast cancer referred for BRCA1 and BRCA2 testing using next-generation sequencing with a 25-gene panel

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

The breast cancer susceptibility mutation PALB2 1592delT is associated with an aggressive tumor phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

PALB2/FANCN: Recombining Cancer and Fanconi Anemia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Tumour morphology predicts PALB2 germline mutation status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Population screening for cancer family syndromes in the west pomeranian region of poland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Prevalent cases in observational studies of cancer survival: do they bias hazard ratio estimates?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2970142-7

7 January 2021

10.1016/S1470-2045(15)70142-7

Identifiers

DOI

1 reference

8 October 2017

1 reference